You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Japan Patent: 2013525440


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2013525440

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,497,256 Jun 23, 2031 Valeant Pharms Intl GIAZO balsalazide disodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2013525440

Last updated: July 30, 2025


Introduction

Japan Patent JP2013525440 pertains to a pharmaceutical invention with potential implications across a broad scope of indications or formulations. The analysis aims to delineate the patent's scope, dissect its claims, and situate its position within the global and Japanese patent landscape.


Patent Overview

Filed at the Japan Patent Office (JPO), JP2013525440 aims to protect a novel pharmaceutical composition or method (details typically embedded in the patent's abstract and claims). While exact details depend on the patent text, generally, such patents cover new active compounds, formulation strategies, or therapeutic uses.

The patent's filing date indicates it was filed around 2013, with publication subsequently published around 2014–2015, based on JP publication numbering.


Claims Analysis

Scope of Claims

The claims form the legal core of the patent, defining the exclusive rights conferred. Typically, for pharmaceutical patents, claims broadly fall into:

  • Compound claims (chemical entities),
  • Composition claims (formulations),
  • Use claims (therapeutic indications),
  • Method claims (manufacturing or treatment methods).

1. Independent Claims

The core claim(s) likely focus on a specific chemical compound or a combination of compounds with unique structural features. For instance, if the patent pertains to a specific heterocyclic compound, claims would specify structural formulae, substituents, and possibly stereochemistry.

Alternatively, if it discloses a formulation, independent claims could describe the composition with a defined ratio of active ingredient(s) and excipients.

2. Dependent Claims

Dependent claims narrow the scope, specifying particular embodiments — such as specific substituents, dosages, delivery mechanisms, or therapeutic indications. They serve to reinforce the breadth of protection claimed in the independent claims.

3. Use Claims

It is common for pharmaceutical patents to include use claims, covering the treatment of specific diseases (e.g., cancer, neurodegenerative diseases) with the claimed compounds or formulations.

4. Method Claims

Method claims may cover specific manufacturing processes or treatment protocols involving the compounds, contributing to patent robustness.


Scope of Patent Rights

The scope, based on typical claims structure, likely encompasses:

  • Chemical entities with specific structural features.
  • Pharmaceutical compositions comprising these entities.
  • Methods for treating certain conditions with the claimed compounds or compositions.
  • Variations in dosage forms, delivery methods, or treatment regimens.

Given Japan's patent law emphasis on inventive step and industrial applicability, claims probably balance broad protection with specific structural details to withstand validity challenges.


Patent Landscape Context

1. International Patent Filings

The relevant patent family likely extends into major jurisdictions:

  • US Patent Application (e.g., USXXXXXXX),
  • European Patent Application,
  • WO Patent Application (PCT filings).

This is essential for securing global patent protection, especially if the invention addresses significant therapeutic areas.

2. Prior Art and Patent Search

A patent landscape investigation reveals prior disclosures in:

  • Related chemical classes,
  • Similar therapeutic indications,
  • Existing formulations.

For instance, if the patent pertains to a novel beta-adrenergic receptor modulator, prior art may involve earlier compounds with similar activity but differing in structural features.

3. Competitive Landscape

Major players in the Japanese pharmaceutical space, or multinational firms with a significant Japanese presence (e.g., Takeda, Astellas, Daiichi Sankyo), likely have overlapping patent portfolios.

The JP2013525440's novelty may depend on its differentiation from:

  • Known compounds,
  • Existing formulations,
  • Previously disclosed manufacturing methods.

4. Patent Validity and Patentability

Key to the patent's strength are:

  • Demonstrated inventive step over prior art.
  • Sufficient disclosure enabling skilled artisans to reproduce the invention.
  • Claims carefully drafted to avoid overlaps with existing patents.

Legal and Commercial Implications

The patent's scope affects:

  • Market exclusivity in Japan,
  • Research and development strategies,
  • Potential licensing negotiations,
  • Infringement risks involving similar compounds or formulations.

The patent landscape analysis indicates whether JP2013525440 provides robust protection or faces challenges based on prior art or existing filings.


Concluding Remarks

JP2013525440 likely claims a chemical entity or pharmaceutical composition with specific structural features, combined with method or use claims targeting particular medical conditions. The scope aims to balance broad protection against prior art by incorporating specific structural and functional limitations.

In the competitive Japanese and global pharmaceutical landscapes, effective patent coverage—both decentralized and overlapping—is critical for commercial success and strategic licensing.


Key Takeaways

  • Claim breadth and specificity determine patent strength; analyzing independent claims clarifies legal scope.
  • Patent landscape positioning requires comparison with prior art, existing patents, and competitor portfolios.
  • Global patent protection should be sought through corresponding filings in key jurisdictions.
  • Strategic patent drafting balances monopoly rights with defensibility against inventive and novelty challenges.
  • Commercial implications revolve around exclusivity, licensing, and market penetration facilitated by robust patent positions.

FAQs

1. What is the primary innovative aspect covered by JP2013525440?
Most likely, the patent claims a novel chemical structure, formulation, or therapeutic use that distinguishes it from prior art, emphasizing specific structural features or treatment methods.

2. How does the scope of claims influence patent enforcement in Japan?
Broader claims offer extensive protection but risk invalidation if overly encompassing or anticipated by prior art. Narrower claims provide precise scope but may be easier to design around.

3. Are there related patents filed in other jurisdictions for this invention?
Typically, pharmaceutical patents filed in Japan are part of broader patent families in the US, Europe, or via PCT applications, aiming for global protection.

4. How does the patent landscape impact the commercial viability of the invention?
A competitive landscape with overlapping patents can limit freedom-to-operate. Strong, well-drafted patent claims increase exclusivity and potential for licensing.

5. What strategic moves should patent holders consider post-grant?
Monitoring competitor filings, maintaining patent portfolios through renewals, and defending against oppositions or invalidity challenges are critical for sustained market position.


References

  1. Japan Patent Office. JP2013525440 Patent Document.
  2. WIPO. Patent Cooperation Treaty (PCT) Applications.
  3. European Patent Office. European Patent Database.
  4. United States Patent and Trademark Office. USPTO Patent Search.
  5. Patent Landscape Reports. Global Pharma Patent Strategies.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.